Fc‐engineered EGF‐R antibodies mediate improved antibody‐dependent cellular cytotoxicity (ADCC) against <i>KRAS</i>‐mutated tumor cellsMartin Schlaeth, Thomas Valerius|Cancer Science|2010Cited by 44